BTDR vs. EBS
BTDR (Bitdeer Technologies Group Class A Ordinary Shares) and EBS (Emergent BioSolutions Inc.) are both stocks. BTDR operates in Software - Application (Technology), while EBS operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 3 years, BTDR returned 59.58%/yr vs -1.27%/yr for EBS. At a 0.27 correlation, their price movements are largely independent.
Performance
BTDR vs. EBS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BTDR achieves a 75.83% return, which is significantly higher than EBS's -35.84% return.
BTDR
- 1D
- 5.06%
- 1M
- 62.09%
- YTD
- 75.83%
- 6M
- 56.30%
- 1Y
- 52.67%
- 3Y*
- 59.58%
- 5Y*
- —
- 10Y*
- —
EBS
- 1D
- -3.41%
- 1M
- -7.14%
- YTD
- -35.84%
- 6M
- -31.64%
- 1Y
- 23.71%
- 3Y*
- -1.27%
- 5Y*
- -34.22%
- 10Y*
- -15.21%
BTDR vs. EBS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
BTDR Bitdeer Technologies Group Class A Ordinary Shares | 75.83% | -48.27% | 119.78% | -1.40% |
EBS Emergent BioSolutions Inc. | -35.84% | 29.29% | 298.33% | -80.98% |
Correlation
The correlation between BTDR and EBS is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2023 | 0.27 |
Fundamentals
BTDR:
-$2.23
EBS:
-$0.37
BTDR:
6.03
EBS:
0.49
BTDR:
$739.06M
EBS:
$676.80M
BTDR:
$25.18M
EBS:
$292.40M
BTDR:
$59.65M
EBS:
$126.60M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTDR vs. EBS — Risk / Return Rank
BTDR
EBS
BTDR vs. EBS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BTDR | EBS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.24 | ||
| Sortino ratioReturn per unit of downside risk | +0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.15 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.74 | 0.55 | +0.19 |
| Martin ratioReturn relative to average drawdown | 1.24 | 1.03 | +0.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BTDR | EBS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.53 | 0.29 | +0.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.34 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.20 | -0.03 | +0.22 |
Drawdowns
BTDR vs. EBS - Drawdown Comparison
The maximum BTDR drawdown since its inception was -79.52%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for BTDR and EBS.
Loading charts...
Drawdown Indicators
| BTDR | EBS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.52% | -98.89% | +19.37% |
Max Drawdown (1Y)Largest decline over 1 year | -71.89% | -43.53% | -28.36% |
Max Drawdown (3Y)Largest decline over 3 years | -79.52% | -84.58% | +5.06% |
Max Drawdown (5Y)Largest decline over 5 years | — | -97.73% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.89% | — |
Current DrawdownCurrent decline from peak | -24.48% | -94.12% | +69.64% |
Average DrawdownAverage peak-to-trough decline | -43.78% | -41.07% | -2.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.65% | 23.11% | +19.54% |
Volatility
BTDR vs. EBS - Volatility Comparison
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) has a higher volatility of 34.35% compared to Emergent BioSolutions Inc. (EBS) at 17.24%. This indicates that BTDR's price experiences larger fluctuations and is considered to be riskier than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTDR | EBS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 34.35% | 17.24% | +17.11% |
Volatility (6M)Calculated over the trailing 6-month period | 67.55% | 47.98% | +19.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.00% | 82.42% | +17.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.89% | 102.17% | +20.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 122.89% | 79.95% | +42.94% |
Dividends
BTDR vs. EBS - Dividend Comparison
Neither BTDR nor EBS has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
BTDR Bitdeer Technologies Group Class A Ordinary Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EBS Emergent BioSolutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.65% |
Financials
BTDR vs. EBS - Financials Comparison
This section allows you to compare key financial metrics between Bitdeer Technologies Group Class A Ordinary Shares and Emergent BioSolutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BTDR vs. EBS - Profitability Comparison
BTDR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bitdeer Technologies Group Class A Ordinary Shares reported a gross profit of -39.04M and revenue of 188.93M. Therefore, the gross margin over that period was -20.7%.
EBS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a gross profit of 61.20M and revenue of 156.10M. Therefore, the gross margin over that period was 39.2%.
BTDR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bitdeer Technologies Group Class A Ordinary Shares reported an operating income of -86.73M and revenue of 188.93M, resulting in an operating margin of -45.9%.
EBS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported an operating income of 0.00 and revenue of 156.10M, resulting in an operating margin of 0.0%.
BTDR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bitdeer Technologies Group Class A Ordinary Shares reported a net income of -159.53M and revenue of 188.93M, resulting in a net margin of -84.4%.
EBS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a net income of 0.00 and revenue of 156.10M, resulting in a net margin of 0.0%.
Frequently Asked Questions
BTDR and EBS have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BTDR has higher volatility (34.35%) compared to EBS (17.24%). In terms of maximum drawdown, BTDR dropped -79.52% vs EBS's -98.89%.
BTDR currently has the higher Sharpe Ratio (0.53 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BTDR and EBS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer